Inhibitors of the TGF-β superfamily and their clinical applications

K. Tsuchida, Y. Sunada, S. Noji, T. Murakami, A. Uezumi, M. Nakatani

研究成果: Review article査読

32 被引用数 (Scopus)

抄録

The transforming growth factor-β (TGF-β) superfamily includes TGF-β s, activin, myostatin and bone morphogenetic proteins. Misregulation of the activity of TGF-β family members is involved in pathogenesis of cancer, muscular dystrophy, obesity and bone and tooth remodeling. Natural inhibitors for the TGF-β superfamily regulate fine-tuning of activity of TGF-β family in vivo. In addition to natural inhibitors for the TGF-β family, soluble forms of receptors for the TGF-β family, blocking monoclonal antibodies and small chemical TGF-β inhibitors have been developed. In this review, we summarize recent advances in our understanding of inhibitors for the TGF-β superfamily and their medical applications.

本文言語English
ページ(範囲)1255-1261
ページ数7
ジャーナルMini-Reviews in Medicinal Chemistry
6
11
DOI
出版ステータスPublished - 11-2006

All Science Journal Classification (ASJC) codes

  • 分子医療
  • 薬理学
  • 創薬
  • 癌研究

フィンガープリント

「Inhibitors of the TGF-β superfamily and their clinical applications」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル